Feldan Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Feldan Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11202
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Feldan Therapeutics Inc (Feldan), formerly Feldan Bio Inc, is a biotechnology company with focus on the discovery, development, manufacture and marketing of recombinant proteins. The company developed a peptide-based technology platform, the Feldan Shuttle for intracellular delivery of proteins inside all cell types including human primary cells. Feldan’s pipeline of regenerative medicine therapeutic applications include FS-001, a Natural Killer (NK) cell-based immunotherapy program transmitting CRISPR nucleases in NK cells to eliminate viral-infected and tumor cells; FS-002, an intracellular antibody delivery program that targets intracellular proteins and regulates therapeutically relevant pathways. The company offers recombinant proteins, monoclonal antibodies and transfection reagents to life science companies and research laboratories. Feldan is headquartered in Quebec, Canada.

Feldan Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Feldan Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Feldan Therapeutics Raises USD9.6 Million in Series A Financing 11
Feldan Bio Raises USD1.4 Million in Fourth Round of Financing 12
Partnerships 13
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 13
Elasmogen, Feldan Bio Enter into Agreement with Amgen 14
Feldan Bio and Elasmogen Enter into Development Partnership 15
Feldan Therapeutics Inc – Key Competitors 16
Feldan Therapeutics Inc – Key Employees 17
Feldan Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Oct 12, 2018: University of Iowa and Feldan Therapeutics awarded grant by the National Institutes of Health 19
Mar 29, 2018: CQDM will partner with Feldan to support a $1.2M project 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Feldan Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Feldan Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Feldan Therapeutics Raises USD9.6 Million in Series A Financing 11
Feldan Bio Raises USD1.4 Million in Fourth Round of Financing 12
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 13
Elasmogen, Feldan Bio Enter into Agreement with Amgen 14
Feldan Bio and Elasmogen Enter into Development Partnership 15
Feldan Therapeutics Inc, Key Competitors 16
Feldan Therapeutics Inc, Key Employees 17

List of Figures
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Feldan Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Feldan Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Company KazMunayGas:企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Curtiss-Wright Corporation (CW)-エネルギー分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • Vitrolife AB (VITR):医療機器:M&Aディール及び事業提携情報
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as follicle aspiration needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation …
  • ASUSTeK Computer Inc. (2357):企業の財務・戦略的SWOT分析
    ASUSTeK Computer Inc. (2357) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Andritz AG (ANDR):企業の財務・戦略的SWOT分析
    Andritz AG (ANDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Union Bank of Taiwan:企業の戦略・SWOT・財務情報
    Union Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Union Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Duskin Co Ltd:企業の戦略・SWOT・財務情報
    Duskin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Duskin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • Groupe Lactalis S.A.:企業の戦略・SWOT・財務情報
    Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Galderma SA:医療機器:M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Itochu Enex Co Ltd (8133):企業の財務・戦略的SWOT分析
    Itochu Enex Co Ltd (8133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug pro …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company. It focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatment …
  • Alstom SA (ALO):電力:M&Aディール及び事業提携情報
    Summary Alstom SA (Alstom) is a marketer and developer of transport systems. The company offers a wide range of solutions ranging from high-speed trains to metros and tramways including customized services such as maintenance and modernization, and infrastructure up to signaling solutions. It design …
  • Charoen Pokphand Foods Public Co Ltd (CPF):企業の戦略的SWOT分析
    Charoen Pokphand Foods Public Co Ltd (CPF) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Empresa Nacional del Petroleo:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • GlobalSCAPE Inc (GSB):企業の財務・戦略的SWOT分析
    Summary GlobalSCAPE Inc (GlobalSCAPE) is a technology company that offers secure information exchange solutions. The company offers EFT platform products such as EFT enterprise, EFT express, public and private cloud, collaboration, automation and efficiency, protocols, security, compliance and analy …
  • Ingersoll-Rand Plc (IR):電力:M&Aディール及び事業提携情報
    Summary Ingersoll-Rand Plc (Ingersoll-Rand) is an industrial manufacturer. It designs, manufactures, sells and services a portfolio of industrial and commercial products. The company’s offerings enhance the quality, energy efficiency and comfort of air in homes and buildings, transport and protect f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆